Integration of hepatitis B vaccination into the expanded programme on immunization in Chonburi and Chiangmai provinces, Thailand

被引:29
作者
Chunsuttiwat, S
Biggs, BA
Maynard, J
Thamapalo, S
Laoboripat, S
Bovornsin, S
Charanasri, U
Pinyowiwat, W
Kunasol, P
机构
[1] MACFARLANE BURNET CTR MED RES, MELBOURNE, VIC, AUSTRALIA
[2] MINIST PUBL HLTH, BANGKOK, THAILAND
[3] ROYAL MELBOURNE HOSP, DEPT MED, WALTER & ELIZA HALL INST MED RES, MELBOURNE, VIC, AUSTRALIA
[4] INT TASK FORCE HEPATITIS IMMUNOL, SEATTLE, WA USA
[5] PROGRAM APPROPRIATE TECHNOL HLTH, SEATTLE, WA USA
关键词
D O I
10.1016/S0264-410X(96)00226-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatitis B (HB) immunization was introduced as part of the expanded programme on immunization (EPI) in two provinces in Thailand and evaluated over a four year period. Three doses of HB vaccine were offered to 60980 newborns at birth, 2 and 6 months of age. The overall coverage for complete HB immunization was 90.4%. Serosurveys of randomly selected children under the age of 5 years were undertaken before and at the end of the project. Levels of HBsAg positivity were reduced by 85%, and there was a corresponding 70% increase in protective immunity. These findings demonstrate that HB immunization can be successfully integrated into EPI without adverse effect on coverage rates of other antigens, and results in a marked reduction in the rate of chronic carriage of HB virus in preschool age children. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:769 / 774
页数:6
相关论文
共 20 条
[1]  
BEASLEY RP, 1983, LANCET, V2, P1099
[2]  
BEASLEY RP, 1981, LANCET, V2, P1129
[3]   HEPATOCELLULAR-CARCINOMA AND HEPATITIS-B VIRUS [J].
BEASLEY, RP ;
HWANG, LY .
SEMINARS IN LIVER DISEASE, 1984, 4 (02) :113-121
[4]   A PILOT MODEL OF VACCINATION AGAINST HEPATITIS-B VIRUS SUITABLE FOR MASS VACCINATION CAMPAIGNS IN HYPERENDEMIC AREAS [J].
DAVILLA, G ;
PIAZZA, M ;
IORIO, R ;
PICCIOTTO, L ;
PELUSO, P ;
DELUCA, G ;
BASILE, B .
JOURNAL OF MEDICAL VIROLOGY, 1992, 36 (04) :274-278
[5]  
*GAMB HEP STUD GRO, 1989, LANCET 0513, P1057
[6]   EPIDEMIOLOGIC STUDY OF HEPATITIS B VIRUS IN BANGKOK, THAILAND [J].
GROSSMAN, RA ;
BENENSON, MW ;
SCOTT, RM ;
SNITBHAN, R ;
TOP, FH ;
PANTUWATANA, S .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1975, 101 (02) :144-159
[7]   LONG-TERM IMMUNOGENICITY AND EFFICACY OF HEPATITIS-B VACCINE IN HOMOSEXUAL MEN [J].
HADLER, SC ;
FRANCIS, DP ;
MAYNARD, JE ;
THOMPSON, SE ;
JUDSON, FN ;
ECHENBERG, DF ;
OSTROW, DG ;
OMALLEY, PM ;
PENLEY, KA ;
ALTMAN, NL ;
BRAFF, E ;
SHIPMAN, GF ;
COLEMAN, PJ ;
MANDEL, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (04) :209-214
[8]   EFFICACY OF A MASS HEPATITIS-B VACCINATION PROGRAM IN TAIWAN - STUDIES ON 3464 INFANTS OF HEPATITIS-B SURFACE-ANTIGEN CARRIER MOTHERS [J].
HSU, HM ;
CHEN, DS ;
CHUANG, CH ;
LU, JCF ;
JWO, DM ;
LEE, CC ;
LU, HC ;
CHENG, SH ;
WANG, YF ;
WANG, CYC ;
LO, KJ ;
SHIH, CJ ;
SUNG, JL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (15) :2231-2235
[9]  
*INT TASK FORC, 1988, HEP B IMM PROGR, P1
[10]  
Lieming Ding, 1993, Clinical Infectious Diseases, V17, P475